Welcome to our dedicated page for Usana Health Sciences news (Ticker: USNA), a resource for investors and traders seeking the latest updates and insights on Usana Health Sciences stock.
USANA Health Sciences, Inc. develops and manufactures nutritional supplements, functional foods, personal care and skincare products sold directly to Brand Partners and Preferred Customers across 25 global markets. Company news regularly centers on earnings releases, management commentary, omnichannel strategy, product innovation and channel expansion.
Recurring updates also cover product launches and quality validation for brands such as CellSentials, Celavive and Glow, along with the company’s controlling stake in Hiya Health Products, its ownership of Rise Wellness, athlete sponsorships and USANA Foundation activity.
USANA (NYSE: USNA) announced on March 24, 2026 that its flagship CellSentials supplement earned the ConsumerLab.com Seal of Approval for purity, potency, and label accuracy.
The formula delivers >40 essential nutrients, now includes PQQ for mitochondrial support, and passed contaminant screenings according to the company.
USANA (NYSE:USNA) congratulated 190 USANA-sponsored athletes who competed at the 2026 Winter Olympic Games, earning a record 28 medals across 12 winter sports while representing eight national teams from four countries.
Highlights include US Ski & Snowboard’s 17 medals, Alex Ferreira’s first Olympic gold in men’s freeski halfpipe, and US Speedskating adding five medals including an Olympic record in the men’s 1000m. USANA noted its Salt Lake City facility is NSF/ANSI GMP and NSF Certified for Sport®.
USANA Health Sciences (NYSE: USNA) will participate in two investor conferences in March 2026: the Sidoti Small-Cap Virtual Conference (March 18-19) and the 38th Annual ROTH Conference (March 23) in Dana Point, CA.
A live webcast of the Sidoti fireside chat will be available and archived in the company’s News/Events section at ir.usana.com.
USANA (NYSE: USNA) Chairman & CEO Kevin Guest used National Reading Month (March 2026) to promote disciplined reading as a leadership tool. Guest links intentional reading to improved decision-making, communication, innovation, and character development, and says he has asked USANA management to adopt book-based practices. Proceeds from Guest's book fund USANA Foundation meal programs.
Rise Wellness (NASDAQ:USNA) launched Protein Pop Plus, a clear, carbonated 12-ounce protein beverage delivering 30 grams of protein per can, now available at all 607 Costco locations nationwide as of Feb. 25, 2026.
Protein Pop Plus blends whey protein isolate and bovine collagen, contains zero sugar and no artificial sweeteners, is gluten free, and ships in 15‑packs across three flavors: Citrus, Mango Peach, and Orange Cream.
USANA (NYSE:USNA) reported fiscal Q4 2025 and full-year results with consolidated net sales of $226.2M in Q4 and $925.3M for FY2025. GAAP net earnings fell to $10.8M for the year versus $42.0M a year earlier, while adjusted EBITDA was $101.3M.
The company forecasts FY2026 consolidated net sales of $925M–$1.0B, adjusted diluted EPS of $1.95–$2.29, and expects Hiya and Rise Wellness to drive non-core growth.
USANA (NYSE: USNA) Executive Chairman & CEO Kevin Guest marks Self-Renewal Day (Feb 2, 2026) as a call for leaders to break comfort zones and pursue deliberate growth. Guest outlines six concrete steps—personal audit, values, one courageous decision, high-value relationships, positive self-talk, resilience—to drive long-term strategic renewal. Proceeds from his book All the Right Reasons benefit the USANA Foundation; each purchase provides 40 meals and the foundation has delivered over 112 million meals to date.
USANA (NYSE: USNA) provided preliminary fiscal 2025 net sales of approximately $925 million, modestly above prior guidance of ~$920 million, and issued initial fiscal 2026 net sales outlook of $925 million to $1.0 billion. The fiscal 2026 outlook is broken down as: USANA core $720–$765M (vs ~777M in FY2025), Hiya $140–$155M (vs ~132M), and Rise Wellness $65–$80M (vs ~16M). Fiscal 2026 is a 52-week year (one week fewer sales vs FY2025). Rise expects breakeven operating margins in FY2026 while the company invests in inventory, capex and working capital. Final results and updated guidance will be released after market on Feb 17, 2026.
USANA Health Sciences (NYSE: USNA) announced a leadership transition effective January 8, 2026: Kevin Guest returns as Chief Executive Officer and will continue as Chairman, succeeding Jim Brown who stepped down as CEO and President. Guest has more than three decades at USANA, including eight prior years as CEO and three years as Executive Chairman. The Board said the change aims to accelerate strategic priorities, leverage Guest’s sales and organizational experience, and drive the company’s next phase of sustainable growth.
USANA (NYSE: USNA) Executive Chairman Kevin Guest on Jan 5, 2026 urged leaders to adopt a growth mindset for lasting achievement and fulfillment.
Guest highlights four traits—resilience, curiosity, purpose, and awareness—and four starter strategies: find mentors, practice positive self-talk, serve others, and trust intuition. He is author of All the Right Reasons, with all proceeds benefiting the USANA Foundation; each book purchase provides 40 meals and the foundation has delivered over 112 million meals. The company operates in 25 countries. For more, visit www.kevinguest.com.